CNE000000KV1
CNE000000KV1
NANJING PHARMACEUTICAL GP CO LT
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 6.72B EUR | 6.54B EUR | 6.91B EUR | 7.15B EUR |
Enterprise Value | 19.57B EUR | 13.36B EUR | 14.41B EUR | 9.93B EUR |
Valuation Multiples | ||||
Trailing P/E | 11.95x | 12.64x | 13.52x | 13.9x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 0.12x | 0.16x | 0.17x | 0.17x |
Price to Book | 0.93x | 0.9x | 0.94x | 0.99x |
EV/Revenue | 0.36x | 0.32x | 0.35x | 0.24x |
EV/EBITDA | 13.3x | 9.67x | 10.22x | 9.92x |
Price to FCF (P/FCF) | -- | -- | -- | 8.69x |
EV/FCF | -- | -- | -- | 12.08x |
FCF Yield | -17.06% | -4.19% | -11.19% | 11.51% |